Gain Therapeutics, Inc. (GANX) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $4.25M | -11.1% |
| 2024 | $4.78M | -20.7% |
| 2023 | $6.03M | +15.5% |
| 2022 | $5.22M | +25.3% |
| 2021 | $4.17M | +22.5% |
| 2020 | $3.40M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $4.25M | -11.1% |
| 2024 | $4.78M | -20.7% |
| 2023 | $6.03M | +15.5% |
| 2022 | $5.22M | +25.3% |
| 2021 | $4.17M | +22.5% |
| 2020 | $3.40M | — |